Holen Sie sich die Stockscreener-App
116.69
3.48%
3.92
Handel nachbörslich:
116.69
Glaukos Corporation Aktie (GKOS) Neueste Nachrichten
Glaukos to Present Multiple Scientific Abstracts at ASCRS Annual Meeting - National Today
Glaukos to Present Multiple Scientific Abstracts at the 2026 American Society of Cataract and Refrac - PharmiWeb.com
Capricorn Fund Managers Ltd Invests $6.78 Million in Glaukos Corporation $GKOS - marketbeat.com
Q4 2024 Glaukos Corp Earnings Call Transcript - GuruFocus
Glaukos (NYSE: GKOS) CDO reports RSU tax withholding transactions - stocktitan.net
Glaukos (NYSE: GKOS) CFO withholds 1,589 shares for RSU tax obligations - stocktitan.net
Glaukos (GKOS) president uses 3,169 shares to cover tax withholding - stocktitan.net
Glaukos (GKOS) CEO gifts 180,308 shares to family trust - stocktitan.net
Glaukos Corp. Experiences Evaluation Revision Amidst Mixed Market Signals and Volatility - Markets Mojo
Cash per share of Glaukos Corp – DUS:6GJ - TradingView
Glaukos Corp (NYSE:GKOS) Shows High-Growth Momentum and Fits Key Trend Template Rules - ChartMill
Glaukos Corporation $GKOS Shares Acquired by Allspring Global Investments Holdings LLC - marketbeat.com
GLAUKOS (GKOS) CDO has 5,798 shares withheld to cover RSU tax - stocktitan.net
Glaukos Corporation (GKOS) Stock Forecasts - Yahoo Finance
GKOS PE Ratio & Valuation, Is GKOS Overvalued - Intellectia AI
SG Americas Securities LLC Purchases 49,492 Shares of Glaukos Corporation $GKOS - marketbeat.com
Why Glaukos Stock Jumped Over 20% After-Hours Today - MSN
Alex Thurman: ‘Phenomenal Year’ for Glaukos - Orange County Business Journal
Price-Driven Insight from (GKOS) for Rule-Based Strategy - Stock Traders Daily
GKOS SEC FilingsGlaukos Corp 10-K, 10-Q, 8-K Forms - stocktitan.net
Aug Chart Watch: Does Glaukos Corporation stock have upside surprise potential2026 Major Catalysts & Advanced Swing Trade Entry Plans - baoquankhu1.vn
Glaukos breaks ground on $80M R&D, manufacturing facility in Alabama - MSN
Glaukos (NYSE:GKOS) CFO Sells $267,321.06 in Stock - marketbeat.com
Glaukos SVP Thurman sells $267k in GKOS stock - Investing.com
Glaukos SVP Thurman sells $267k in GKOS stock By Investing.com - Investing.com South Africa
Glaukos (NYSE: GKOS) president reports new stock and option grants - Stock Titan
Glaukos (NYSE: GKOS) CFO gets new equity awards and sells shares - Stock Titan
Glaukos Corporation (NYSE:GKOS): Is Breakeven Near? - 富途牛牛
Glaukos launches Epioxa, boosts growth in corneal treatments - MSN
Riverbridge Partners LLC Sells 34,475 Shares of Glaukos Corporation $GKOS - MarketBeat
Assenagon Asset Management S.A. Has $20.59 Million Stock Position in Glaukos Corporation $GKOS - MarketBeat
Glaukos (GKOS) CEO gains RSUs and options after targets met - stocktitan.net
Glaukos (GKOS) Is Up 5.5% After Launching Incision-Free Epioxa Therapy For KeratoconusWhat's Changed - simplywall.st
Vanguard realigns reporting; Vanguard subsidiaries to report GKOS holdings (GKOS) - Stock Titan
Insider Selling: Glaukos (NYSE:GKOS) CFO Sells 1,521 Shares of Stock - MarketBeat
Glaukos CFO Thurman sells $160k in shares By Investing.com - Investing.com South Africa
Glaukos CFO Thurman sells $160k in shares - Investing.com
Glaukos (GKOS) CEO uses 2,744 shares to cover equity tax withholding - Stock Titan
Glaukos (GKOS) president sees 15,118 shares withheld to cover tax obligations - Stock Titan
Glaukos (NYSE: GKOS) insider plans sale of 2,511 vested shares - stocktitan.net
Glaukos (NYSE: GKOS) CFO sale and tax share withholdings detailed - stocktitan.net
Glaukos (GKOS) affiliate files to sell 1,521 shares after vesting - Stock Titan
Glaukos Corp Stock Faces Monthly Pressure Amid Analyst Optimism and Glaucoma Innovation Push - AD HOC NEWS
Piper Sandler reiterates Glaukos stock rating on growth outlook - Investing.com UK
Piper Sandler reiterates Glaukos stock rating on growth outlook By Investing.com - Investing.com Australia
Why is Glaukos (GKOS) down 14.7% since last earnings report? - MSN
JPMorgan Chase & Co. Has $54.65 Million Stock Position in Glaukos Corporation $GKOS - marketbeat.com
Glaukos Introduces Epioxa, Accelerating Expansion in Corneal Therapy - Bitget
Glaukos Announces Commercial Availability of Epioxa, a Transformative Innovation in Interventional Keratoconus Care - marketscreener.com
Glaukos Corp. Experiences Revision in Stock Evaluation Amid Mixed Technical Indicators - Markets Mojo
Glaukos Launches Epioxa, Boosts Growth in Corneal Treatments - Yahoo Finance Singapore
Glaukos (GKOS) Launches Epioxa HD for Keratoconus Treatment - GuruFocus
Glaukos Corporation (NYSE:GKOS) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Glaukos Announces Commercial Availability of Epioxa for Incision-Free Keratoconus Care - visionmonday.com
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):